Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
startups
3
×
biotech
boston blog main
boston top stories
cancer
deals
gene therapy
life sciences
national blog main
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
zolgensma
abbvie
adalimumab (humira)
adeno-associated virus
aducanumab
aduro biotech
affordable care act
alexandria venture investments
alez azar
altitude life science ventures
alzheimer's disease
american society of gene and cell therapy
antibiotics
arch venture partners
axial spondyloarthritis
bausch health
bio
biogen
boston university
boulder/denver blog main
boulder/denver top stories
boxer capital
bristol-myers squibb
california
What
remains
3
×
progress
according
approval
attacks
bio
biogen’s
biopharmaceutical
bioscience
cancer
companies
convo
counterpoint
crude
cutting
despite
diagnosis
died
disease
drug
earlier
edge
effects
encoded
failures
gene
globally
health
help
history
human
illumina’s
initial
lasting
limited
limits
littered
long
march
medical
Language
Current search:
remains
×
startups
×
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
4 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@techcrunch.com
6 years ago
Tradewind Bioscience attacks the physiology of tumors to treat cancer